Blood pressure control in Italy: Results of recent surveys on hypertension

Journal of Hypertension

Volumn 25, Issue 7, 2007, Pages 1491-1498

  Volpe, Massimo ^a,b   Tocci, Giuliano ^a   Trimarco, Bruno ^b   Rosei, Enrico Agabiti ^c   Borghi, Claudio ^d   Ambrosioni, Ettore ^d   Menotti, Alessandro ^e   Zanchetti, Alberto ^f   Mancia, Giuseppe ^g  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c SPEDALI CIVILI   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e Association for Cardiac Research   (Italy)

^f ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^g SAN GERARDO HOSPITAL   (Italy)

Author keywords

Blood pressure control; Cardiovascular risk; Hypertension surveys

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ITALY; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SAMPLE SIZE; SYSTOLIC BLOOD PRESSURE;

EID: 34250322546     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3280fa83a6     Document Type: Article

References (34)

1. Burt VL, Cuttler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, et al. Trends in prevalence, awareness, treatment and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension 1995; 26:60-69.
2. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003; 289:2363- 2369.
3. Kearney P, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004; 22:11-19.
4. Mancia G, Sega R, Milesi C, Cesana G, Zanchetti A. Blood pressure control in the hypertensive population. Lancet 1997; 349:454-457.
5. Mancia G, Grassi G. Systolic and diastolic blood pressure control in antihypertensive drug trials. J Hypertens 2002; 20:1461-1464.
6. European Society of Hypertension (ESH)/European Society of Cardiology (ESC). Guidelines for the management of arterial hypertension. J Hypertens 2003; 21:1011-1053.
7. World Health Organization (WHO)/International Society of Hypertension (ISH). Guidelines for the management of hypertension. J Hypertens 1999; 17:151-183.
8. Chobanian A, Bakris G, Black H, Cushman W, Green L, Izzo J, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report. JAMA 2003; 289:2560-2571.
9. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335:765-774.
10. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, for the Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903-1913.
11. Van den Hoogen PC, Feskens EJ, Nagelkerke NJ, Menotti A, Nissinen A, Kromhout D. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group. N Engl J Med 2000; 342:1-8.
12. Turnbull F, Neal B, Algert C, Chalmers J, Chapman N, Cutler J, et al., for the Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood pressure lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus. Arch Intern Med 2005; 165:1410-1419.
13. Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking and death from coronary heart disease. Overall findings and differences by age for 316.099 white men.Multiple Risk Factor Intervention Trial (MRFIT) research group. Arch Intern Med 1992; 152:56-64.
14. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, et al., for the HOT Study Group. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351:1755-1762.
15. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnel CJ, Kannel WB, Levy D. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345:1291-1297.
16. Andersson OK, Almgren T, Persson B, Samuelsson O, Hedner T, Wilhelmsen L. Survival in treated hypertension: follow up study after two decades. BMJ 1998; 317:167-171.
17. Mancia G, Bombelli M, Lanzarotti A, Grassi G, Cesana G, Zanchetti A, Sega R. Systolic vs diastolic blood pressure control in the hypertensive patients of the PAMELA population. Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) Study. Arch Intern Med 2002; 162:582-586.
18. Muiesan ML, Pasini G, Salvetti M, Calebich S, Zulli R, Castellano M, et al. Cardiac and vascular structural changes. Prevalence and relation to ambulatory blood pressure in a middle-aged general population in northern Italy: the Vobarno Study. Hypertension 1996; 27:1046-1052.
19. Menotti A, Lanti M, Zanchetti A, Puddu PE, Cirillo M, Mancini M, Vagnarelli OT. Impact of the GUBBIO population study on community control of blood pressure and hypertension. GUBBIO Study Research Group. J Hypertens 2001; 18:843-850.
20. Verdecchia P, Carini G, Circo A, Dovellini E, Giovannini E, Lombardo M, et al., for the MAssa Ventricolare sinistra nell'Ipertensione (MAVI) Study Group. Left ventricular mass and cardiovascular morbidity in essential hypertension. J Am Coll Cardiol 2001; 38:1829-1835.
21. Schillaci G, Pasqualini L, Verdecchia P, Vaudo G, Marchesi S, Porcellati C, et al., for the PIUMA Study. Prognostic significance of left ventricular diastolic dysfunction in essential hypertension. The Progetto Ipertensione Umbria Monitoraggio Ambulatoriale (PIUMA) Study. J Am Coll Cardiol 2002; 39:2005-2011.
22. Borghi C, Dormi A, D'Addato S, Gaddi A, Ambrosioni E, for the Brisighella Heart Study Working Party. Trends in blood pressure control and antihypertensive treatment in clinical practice: the Brisighella Heart Study. J Hypertens 2004; 22:1707-1716.
23. Cuspidi C, Mancia G, Ambrosioni E, Pessina A, Trimarco B, Banchetti A, on behalf of the APROS Investigators. Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: results from the Assessment Prognostic Risk Observational Survey (APROS). J Hum Hypertens 2004; 18:891-896.
24. Mancia G, Volpe R, Boros S, Ilardi M, Giannattasio C. Cardiovascular risk profile and blood pressure control in Italian hypertensive patients under specialist care. The HORIZON study. J Hypertens 2004; 22:51-57.
25. Cuspidi C, Meani S, Fusi V, Severgnini B, Valerio C, Catini E, et al. Metabolic syndrome and target organ damage in untreated essential hypertensives. J Hypertens 2004; 22:1991-1998.
26. Tocci G, Volpe M, Trimarco B, Mancia G. Cardiovascular risk profile in 14,513 patients with essential hypertension followed by Italian specialist physicians. The Observational Pressure Survey (OPS). High Blood Press Cardiovasc Prev 2004; 11:165-175.
27. Volpe M, Notaro LA, Tocci G, Panina G, Veglia F, Agabiti Rosei E, et al. The REassessment of Antihypertensive Chronic Therapy (REACT) Study: an Italian observational study on hypertension. High Blood Press Cardiovasc Prev 2004; 11:175-185.
28. Mancia G, Pessina AC, Trimarco B, Grassi G, on behalf of the Studio Italiano Longitudinale sulla Valutazione dell Ipertensione Arteriosa nel 2000 (SILVIA) Study Group. Blood pressure control according to new guidelines targets in low-to-high-risk hypertensives managed in specialist practice. J Hypertens 2005; 22:2387-2396.
29. Cuspidi C, Meani S, Fusi V, Valerio C, Catini E, Sala C, et al. Prevalence and correlates of left atrial enlargement in essential hypertension: role of ventricular geometry and the metabolic syndrome: the Evaluation of Target Organ Damage in Hypertension (ETODH) study. J Hypertens 2005; 23:875-882.
30. Mancia G, Ambrosioni E, Rosei EA, Leonetti G, Trimarco B, Volpe M, et al., for the ForLife study group. Blood pressure control and risk of stroke in untreated and treated hypertensive patients screened from clinical practice: results of the ForLife study. J Hypertens 2005; 23:1575-1581.
31. Mancia G, Parati G, Borghi C, Ghironzi G, Andriani E, Marinelli L, et al., on behalf of the SMOOTH investigators. Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the San Marino Observational Outlooking Trial on Hypertension (SMOOTH) study. J Hypertens 2006; 24:837-843.
32. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109:433-438.
33. Sullivan LM, Massaro JM, D'Agostino RB Sr. Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Stat Med 2004; 23:1631-1660.
34. Collins R, Peto R, MacMahon S, Herbert P, Fieback NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335:827-839.